Location History:
- Schwenskville, PA (US) (2016)
- Phoenixville, PA (US) (2021 - 2024)
Company Filing History:
Years Active: 2016-2025
Title: Innovations by Julie Marie Skinner
Introduction
Julie Marie Skinner is a prominent inventor based in Phoenixville, PA (US). She has made significant contributions to the field of immunology, holding a total of 9 patents. Her work focuses on enhancing the immunogenicity of polysaccharide-protein conjugates, which are crucial for developing effective vaccines.
Latest Patents
One of her latest patents involves enhancing the immunogenicity of polysaccharide-protein conjugates. This invention provides immunogenic compositions that include one or more polysaccharide-protein conjugates, where polysaccharides from bacterial capsules are conjugated to a carrier protein in an aprotic solvent such as dimethylsulfoxide (DMSO). The invention also outlines methods for improving the immune response to a pneumococcal polysaccharide protein conjugate vaccine by administering an immunogenic composition prepared under DMSO conditions. Another significant patent relates to multivalent immunogenic compositions that comprise multiple polysaccharide-protein conjugates. These compositions are designed to induce a protective immune response in patients and are useful in treatment regimes that complement existing pneumococcal vaccines.
Career Highlights
Julie Marie Skinner is currently associated with Merck Sharp & Dohme Corporation, where she continues to innovate in the field of immunology. Her work has been instrumental in advancing vaccine technology and improving public health outcomes.
Collaborations
Throughout her career, Julie has collaborated with notable colleagues, including Luwy Kavuka Musey and Chitrananda Abeygunawardana. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Julie Marie Skinner's contributions to immunology through her patents and work at Merck Sharp & Dohme Corporation highlight her role as a leading inventor in the field. Her innovative approaches to vaccine development are paving the way for enhanced immunogenicity and better health outcomes.